Cargando…
High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa
Retinitis pigmentosa is the most frequent group of inherited retinal dystrophies. It is highly heterogeneous, with more than 80 disease-causing genes 27 of which are known to cause autosomal dominant RP (adRP), having been identified. In this study a total of 29 index cases were ascertained based on...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206707/ https://www.ncbi.nlm.nih.gov/pubmed/28045043 http://dx.doi.org/10.1038/srep39652 |
_version_ | 1782490287158853632 |
---|---|
author | Ezquerra-Inchausti, Maitane Barandika, Olatz Anasagasti, Ander Irigoyen, Cristina López de Munain, Adolfo Ruiz-Ederra, Javier |
author_facet | Ezquerra-Inchausti, Maitane Barandika, Olatz Anasagasti, Ander Irigoyen, Cristina López de Munain, Adolfo Ruiz-Ederra, Javier |
author_sort | Ezquerra-Inchausti, Maitane |
collection | PubMed |
description | Retinitis pigmentosa is the most frequent group of inherited retinal dystrophies. It is highly heterogeneous, with more than 80 disease-causing genes 27 of which are known to cause autosomal dominant RP (adRP), having been identified. In this study a total of 29 index cases were ascertained based on a family tree compatible with adRP. A custom panel of 31 adRP genes was analysed by targeted next-generation sequencing using the Ion PGM platform in combination with Sanger sequencing. This allowed us to detect putative disease-causing mutations in 14 out of the 29 (48.28%) families analysed. Remarkably, around 38% of all adRP cases analysed showed mutations affecting the splicing process, mainly due to mutations in genes coding for spliceosome factors (SNRNP200 and PRPF8) but also due to splice-site mutations in RHO. Twelve of the 14 mutations found had been reported previously and two were novel mutations found in PRPF8 in two unrelated patients. In conclusion, our results will lead to more accurate genetic counselling and will contribute to a better characterisation of the disease. In addition, they may have a therapeutic impact in the future given the large number of studies currently underway based on targeted RNA splicing for therapeutic purposes. |
format | Online Article Text |
id | pubmed-5206707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-52067072017-01-04 High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa Ezquerra-Inchausti, Maitane Barandika, Olatz Anasagasti, Ander Irigoyen, Cristina López de Munain, Adolfo Ruiz-Ederra, Javier Sci Rep Article Retinitis pigmentosa is the most frequent group of inherited retinal dystrophies. It is highly heterogeneous, with more than 80 disease-causing genes 27 of which are known to cause autosomal dominant RP (adRP), having been identified. In this study a total of 29 index cases were ascertained based on a family tree compatible with adRP. A custom panel of 31 adRP genes was analysed by targeted next-generation sequencing using the Ion PGM platform in combination with Sanger sequencing. This allowed us to detect putative disease-causing mutations in 14 out of the 29 (48.28%) families analysed. Remarkably, around 38% of all adRP cases analysed showed mutations affecting the splicing process, mainly due to mutations in genes coding for spliceosome factors (SNRNP200 and PRPF8) but also due to splice-site mutations in RHO. Twelve of the 14 mutations found had been reported previously and two were novel mutations found in PRPF8 in two unrelated patients. In conclusion, our results will lead to more accurate genetic counselling and will contribute to a better characterisation of the disease. In addition, they may have a therapeutic impact in the future given the large number of studies currently underway based on targeted RNA splicing for therapeutic purposes. Nature Publishing Group 2017-01-03 /pmc/articles/PMC5206707/ /pubmed/28045043 http://dx.doi.org/10.1038/srep39652 Text en Copyright © 2017, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Ezquerra-Inchausti, Maitane Barandika, Olatz Anasagasti, Ander Irigoyen, Cristina López de Munain, Adolfo Ruiz-Ederra, Javier High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa |
title | High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa |
title_full | High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa |
title_fullStr | High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa |
title_full_unstemmed | High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa |
title_short | High prevalence of mutations affecting the splicing process in a Spanish cohort with autosomal dominant retinitis pigmentosa |
title_sort | high prevalence of mutations affecting the splicing process in a spanish cohort with autosomal dominant retinitis pigmentosa |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206707/ https://www.ncbi.nlm.nih.gov/pubmed/28045043 http://dx.doi.org/10.1038/srep39652 |
work_keys_str_mv | AT ezquerrainchaustimaitane highprevalenceofmutationsaffectingthesplicingprocessinaspanishcohortwithautosomaldominantretinitispigmentosa AT barandikaolatz highprevalenceofmutationsaffectingthesplicingprocessinaspanishcohortwithautosomaldominantretinitispigmentosa AT anasagastiander highprevalenceofmutationsaffectingthesplicingprocessinaspanishcohortwithautosomaldominantretinitispigmentosa AT irigoyencristina highprevalenceofmutationsaffectingthesplicingprocessinaspanishcohortwithautosomaldominantretinitispigmentosa AT lopezdemunainadolfo highprevalenceofmutationsaffectingthesplicingprocessinaspanishcohortwithautosomaldominantretinitispigmentosa AT ruizederrajavier highprevalenceofmutationsaffectingthesplicingprocessinaspanishcohortwithautosomaldominantretinitispigmentosa |